Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation.
The mitochondrial 12S rRNA A1555G mutation is one of the important causes of aminoglycoside-induced and nonsyndromic hearing loss. Here we employed an RNA-directed chemical-modification approach to understanding the pathogenesis of aminoglycoside-induced hearing loss. The patterns of chemical modification of RNA oligonucleotides carrying the A1555G mutation by dimethyl sulfate (DMS) were distinct from those of the RNA oligonucleotides carrying wild-type sequence in the presence of aminoglycosides. In the RNA analogue carrying the A1555G mutation, reduced reactivity to DMS occurred in base G1555 as well as in bases C1556 and A1553 in the presence of paromomycin, neomycin, gentamicin, kanamycin, tobramycin, or streptomycin. In particular, base G1555 exhibited marked but similar levels of protection in the presence of 0.1 microM to 100 microM neomycin, gentamicin, or kanamycin. In contrast, the levels of protection in base G1555 appeared to be correlated with the concentration of paromycin, tobramycin, or streptomycin. Furthermore, increasing reactivities to DMS in the presence of these aminoglycosides were observed for bases A1492, C1493, C1494, and A1557 in the RNA analogue carrying the A1555G mutation. These data suggested that the A1555G mutation altered the binding properties of aminoglycosides at the A site of 12S rRNA and led to local conformational changes in 12S rRNA carrying the A1555G mutation. The interaction between aminoglycosides and 12S rRNA carrying the A1555G mutation provides new insight into the pathogenesis of aminoglycoside ototoxicity.
Qian
Yaping
Y
Division of Human Genetics, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave., Cincinnati, OH 45229-3039, USA.
Guan
Min-Xin
MX
D000617:Aminoglycosides / Q000633:toxicity*; D004272:DNA, Mitochondrial / Q000235:genetics*; D003638:Deafness / Q000139:chemically induced / Q000235:genetics*; D006801:Humans; D009154:Mutation; D012335:RNA, Ribosomal / Q000235:genetics*
D000617:Aminoglycosides; D004272:DNA, Mitochondrial; D012335:RNA, Ribosomal; C075526:RNA, ribosomal, 12S
Hum Mol Genet. 2002 May 15;11(10):1229-40
12015283
Nucleic Acids Res. 1991 Apr 25;19 Suppl:1987-2015
2041797
Nature. 1987 Jun 4-10;327(6121):389-94
2953976
Hum Mol Genet. 1996 Jul;5(7):963-71
8817331
Nature. 1994 Aug 25;370(6491):659-62
8065453
Am J Med Genet A. 2004 Jan 15;124A(2):113-7
14699607
EMBO J. 1998 Nov 16;17(22):6437-48
9822590
Pharmacogenomics. 2005 Jan;6(1):27-36
15723603
Hum Mol Genet. 2001 Mar 15;10(6):573-80
11230176
Mitochondrion. 2011 Mar;11(2):237-45
21047563
Ann N Y Acad Sci. 1991;630:16-31
1952587
J Mol Biol. 1990 Mar 5;212(1):127-33
1690811
Am J Hum Genet. 1998 Jan;62(1):27-35
9490575
Methods Enzymol. 1995;261:323-50
8569502
Antimicrob Agents Chemother. 2006 Apr;50(4):1489-96
16569869
Am J Hum Genet. 2004 Jan;74(1):139-52
14681830
EMBO J. 1989 Apr;8(4):1213-6
2472961
J Mol Biol. 1996 Oct 4;262(4):421-36
8893854
Annu Rev Biochem. 1991;60:191-227
1883196
J Mol Biol. 1986 Feb 5;187(3):399-416
2422386
Nat Genet. 1993 Jul;4(3):289-94
7689389
Eur J Hum Genet. 1996;4(1):46-51
8800928
Methods Enzymol. 1988;164:481-9
2468070
Audiology. 1988;27(3):137-46
3044302
J Biol Chem. 1968 Jun 25;243(12):3312-6
5656371
Biochemistry. 1997 Oct 7;36(40):12323-8
9315872
Science. 1996 Nov 22;274(5291):1367-71
8910275